Lyell Immunopharma (LYEL) Accumulated Depreciation & Amortization (2019 - 2024)
Historic Accumulated Depreciation & Amortization for Lyell Immunopharma (LYEL) over the last 6 years, with Q4 2024 value amounting to $19.6 million.
- Lyell Immunopharma's Accumulated Depreciation & Amortization fell 305.68% to $19.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $19.6 million, marking a year-over-year decrease of 305.68%. This contributed to the annual value of $19.6 million for FY2024, which is 305.68% down from last year.
- Latest data reveals that Lyell Immunopharma reported Accumulated Depreciation & Amortization of $19.6 million as of Q4 2024, which was down 305.68% from $20.2 million recorded in Q4 2023.
- In the past 5 years, Lyell Immunopharma's Accumulated Depreciation & Amortization registered a high of $20.2 million during Q4 2023, and its lowest value of $4.3 million during Q4 2020.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $18.0 million (2022), whereas its average is $15.2 million.
- Per our database at Business Quant, Lyell Immunopharma's Accumulated Depreciation & Amortization soared by 24187.9% in 2020 and then crashed by 305.68% in 2024.
- Quarter analysis of 5 years shows Lyell Immunopharma's Accumulated Depreciation & Amortization stood at $4.3 million in 2020, then soared by 217.28% to $13.6 million in 2021, then surged by 32.27% to $18.0 million in 2022, then rose by 12.38% to $20.2 million in 2023, then dropped by 3.06% to $19.6 million in 2024.
- Its last three reported values are $19.6 million in Q4 2024, $20.2 million for Q4 2023, and $18.0 million during Q4 2022.